✓ Luottokorttimaksut palautettu — turvallinen kassaprosessi Privacy Shieldin kautta

Pantocid Injection

✅ Rapid acid relief
✅ Gastric ulcer healing
✅ Reduces acid reflux
✅ Prevents acid-related damage
✅ Effective GERD treatment

Pantocid Injection contains Pantoprazole.

Lääketieteellinen tarkistus Morgan Ellis — Farmasian tutkija · 8 vuoden kokemus  · Viimeisin arvio: toukokuu 2026

Osta enemmän, säästä enemmän Hinta per pullo
1 Vial/s
US$6.00/vial
6,00 $
2 Vial/s
US$5.75/vial · säästä 4%
US$11.50
3 Vial/s
US$5.50/vial · säästä 8%
US$16,50
6 Vial/s PARAS ARVO
US$4.50/vial · säästä 25%
US$27.00
Salattu kassavaihe
Kryptomaksut 10% halvempia
Hienovaraiset maailmanlaajuiset toimitukset
1 400+ asiakasta · 50+ maata

⚡ Quick Answer — What is Pantocid Injection?

Pantocid Injection on pantoprazole sodium 40 mg per vial for intravenous use, made by Sun Pharma from a WHO-GMP certified manufacturing facility. This is the parenteral form of pantoprazole used in hospital when a patient cannot take oral PPI — nil-by-mouth, post-operative, intubated, or with active upper-GI bleeding. Vakioannos: 40 mg IV once daily reconstituted in 0.9% saline, infused over 15 minutes. For active non-variceal upper-GI bleed with a high-risk endoscopic lesion (Forrest Ia/Ib/IIa/IIb), the protocol is an 80 mg IV bolus followed by an 8 mg/h continuous infusion for 72 hours. Switch to oral pantoprazole (e.g. Pantodac 40 mg) as soon as the patient can swallow safely. Continued IV PPI beyond 3–5 days adds nothing pharmacologically.

Mitä saat MedsBasen kautta: WHO-GMP sertifioitu valmistaja · Hienotunteinen pakkaus · Maailmanlaajuinen toimitus · 1 400+ varmennettua asiakasarviota

📦 Jokainen tilaus on katettuna meidän Reshipment Assurance Policy -politiikkamme piiriin — jos lähetyksesi ei saavu 20 arkipäivässä, lähetämme uuden.

Miksi tilata MedsBasesta

Geneeriset lääkkeemme on hankittu WHO-GMP sertifioiduilta valmistajilta ja toimitettu maailmanlaajuisesti hienotunteisessa, neutraalissa pakkauksessa — lääkkeen nimeä ei ole pakkauksen ulkopuolella. Korttimaksut käsitellään säädeltyjen maksunvälittäjien kautta (tilisiirtojen kuvaukset sisältävät säädellyn korttimaksun käsittelijän — ei koskaan “MedsBase” tai lääkkeen nimeä). Kryptovaluutat ja SEPA-pankkisiirrot hyväksytään myös. Jokainen tilaus on turvattu meidän Reshipment Assurance Policy -takuuohjelmalla.

Hospital-use medication. Pantocid Injection is a parenteral medication intended for inpatient or supervised clinical use. It is supplied as a sterile lyophilised powder vial that must be reconstituted with 0.9% sodium chloride and administered intravenously by a qualified healthcare professional. Self-administration of this product is not appropriate. If you can take an oral PPI, oral pantoprazole (Pantodac, Pan, Pentab, Walapan-40) or any other oral PPI gives equivalent acid suppression at a fraction of the cost.

What Pantocid Injection Is

Pantocid Injection is the Sun Pharma brand of intravenous pantoprazole sodium. Each vial contains pantoprazole sodium equivalent to 40 mg of pantoprazole base, supplied as a sterile lyophilised powder for reconstitution. It is the parenteral form of the same molecule available orally as Pantodac, Pan, Pentab, Penlip, and Walapan-40.

How Pantocid Injection Works

Pantoprazole is a benzimidazole proton-pump inhibitor. After IV administration, the drug is concentrated in the acidic secretory canaliculi of the stomach’s parietal cells. There it is protonated to the active sulphenamide form, which forms a covalent disulphide bond with cysteine residues on the H+/K+-ATPase pump. This irreversibly blocks acid secretion until new pumps are synthesised, giving 24–72 hours of pharmacodynamic effect from each dose despite the drug’s short ~1-hour plasma half-life. Continuous infusion is used for active GI bleeding because it maintains an elevated intragastric pH at > 6 — the threshold above which platelet aggregation is preserved and clot stability is improved.

Indications — When IV Pantoprazole Is Used

1. Active upper-GI bleeding from a peptic ulcer (post-endoscopy)

The largest evidence base. After endoscopic haemostasis of a high-risk lesion (active arterial bleeding Forrest Ia, oozing Ib, non-bleeding visible vessel IIa, or adherent clot IIb), a 72-hour IV PPI infusion at 80 mg bolus + 8 mg/h reduces rebleeding, surgery, and 30-day mortality. Patients with low-risk lesions (Forrest IIc/III) do not need IV therapy and can go straight to oral high-dose pantoprazole.

2. Patients NPO (nil by mouth) needing acid suppression

Post-operative ileus, mechanical ventilation, severe pancreatitis, persistent vomiting, or dysphagia. Once enteral nutrition resumes, switch to oral pantoprazole.

3. ICU stress-ulcer prophylaxis

For mechanically ventilated patients > 48 hours, those with coagulopathy, or those on vasopressors. Note: prolonged ICU PPI use is associated with increased C. difficile infection and ventilator-associated pneumonia — review the indication daily and stop when no longer needed.

4. Zollinger-Ellison syndrome — bridging

For patients with acid hypersecretory states who cannot take oral PPI temporarily.

Dosing and Administration

KäyttöaiheAnnosHuomautuksia
Vakioaikuisannos40 mg IV once dailyReconstitute with 10 mL 0.9% sodium chloride; may further dilute in 100 mL 0.9% NaCl; infuse over 15 minutes
Upper-GI bleed (high-risk lesion, post-endoscopy)80 mg IV bolus, then 8 mg/h continuous infusion72 hours, then step down to oral 40 mg twice daily for 14 days
Severe Zollinger-Ellison80 mg IV every 8–12 hours (specialist-led)0.9% NaCl reconstitution; specialist supervision
MaksavaurioMaximum 40 mg/dayMonitor LFTs
MunuaisvaurioNo dose adjustment neededStandard regimen

Compatibility: Reconstitute only with 0.9% sodium chloride. Do not mix with other IV medications in the same line. The reconstituted solution is stable for 12 hours at room temperature; discard any unused portion.

Switch to oral PPI as soon as the patient can swallow safely. Continued IV PPI beyond 3–5 days has no pharmacological advantage over oral therapy and adds substantially to cost and infection risk.

Haittavaikutukset

Common (1–10%): headache, diarrhoea, nausea, abdominal pain, injection-site reactions (pain, thrombophlebitis at the cannula site).

Epätavallisia mutta tärkeitä: hypersensitivity (rash, angioedema; very rarely anaphylaxis), acute interstitial nephritis, hepatotoxicity (rare), severe hypomagnesaemia (with prolonged use), C. difficile infection (especially in hospitalised patients), and ventilator-associated pneumonia.

Käyttökiellot

  • Known hypersensitivity to pantoprazole or any benzimidazole PPI
  • Concurrent rilpivirine (HIV) — absolute contraindication
  • Severe hepatic impairment — reduce dose

Säilytys

Store unopened vials at 15–30 °C, protected from light. After reconstitution, the solution is stable for 12 hours at room temperature; refrigeration is not required but does not extend stability beyond 24 hours. Discard any visibly discoloured or particulate-containing solution.

Usein Kysytyt Kysymykset

When is IV pantoprazole used instead of oral?

Only when a patient cannot take oral PPI — nil-by-mouth, post-operative, intubated, persistent vomiting, severe dysphagia — or in the specific context of acute upper-GI bleeding where high-dose continuous infusion improves outcomes after endoscopic haemostasis. Once enteral nutrition resumes, oral pantoprazole gives equivalent acid suppression at a fraction of the cost.

Why is the bleeding-protocol dose so much higher (80 mg + 8 mg/h)?

Active upper-GI bleeding requires sustained intragastric pH > 6 to stabilise platelet aggregation and protect the clot from peptic digestion. The 80 mg loading dose plus 8 mg/h continuous infusion is the regimen with the largest randomised-trial evidence base for this. Lower or intermittent dosing produces large pH fluctuations and less rebleeding protection.

How long should IV PPI be continued?

For acute GI bleed, 72 hours of continuous infusion, then step down to oral 40 mg twice daily for 14 days, then once daily. For NPO patients, switch to oral PPI as soon as the gut works. Prolonged IV PPI > 5 days has no pharmacological advantage and increases C. difficile and pneumonia risk in hospital.

Is IV pantoprazole better than IV omeprazole or esomeprazole?

For acid suppression alone, no — all IV PPIs reach equivalent intragastric pH. Pantoprazole is preferred in clinical practice because of its cleaner drug-interaction profile (especially relevant in ICU patients on multiple drugs metabolised by CYP3A4 and CYP2C19) and because the bleeding-protocol evidence base is largest with pantoprazole and esomeprazole.

Can it be mixed with other IV drugs?

No. Reconstitute pantoprazole only with 0.9% sodium chloride and administer through a dedicated IV line. Do not co-administer with other medications in the same line because of compatibility issues with several common IV drugs.

Is IV pantoprazole safe in pregnancy?

Pantoprazole has reasonable pregnancy safety data. IV pantoprazole would be used in pregnancy only when oral therapy is impossible — e.g. hyperemesis gravidarum severe enough to need parenteral nutrition, or acute peptic ulcer bleeding. Discuss with obstetric and GI teams.

What are the side effects of IV pantoprazole?

Most are similar to oral PPI: headache, diarrhoea, nausea. Specific to IV use: injection-site pain or thrombophlebitis at the cannula. Important hospital complications to monitor for: C. difficile infection, ventilator-associated pneumonia, hypomagnesaemia (long ICU stays), and rare acute interstitial nephritis (creatinine rise).

Does IV pantoprazole interact with clopidogrel?

Pantoprazole has the smallest clopidogrel interaction of any PPI because it does not inhibit CYP2C19 to a clinically significant degree. This is one reason it is the default IV PPI in cardiology and cardiac-surgery wards.

Can it be given by a peripheral cannula?

Yes — standard 40 mg dose reconstituted and diluted in 100 mL 0.9% saline can be given through a peripheral line. The 8 mg/h continuous infusion for GI bleed is more often given through a dedicated line because of the duration. Watch for thrombophlebitis at the cannula site.

How is it stored after reconstitution?

The reconstituted and diluted solution is stable for 12 hours at room temperature in 0.9% saline. Refrigeration extends shelf life to 24 hours. Discard any solution that is discoloured, hazy, or contains particulate matter.

Medical disclaimer: This information is for adults under medical supervision. Acid-related disease can have serious underlying causes including peptic ulcer, Barrett’s oesophagus, and gastric cancer — persistent or alarming symptoms (weight loss, dysphagia, vomiting blood, melaena, anaemia, age > 55 with new-onset symptoms) require investigation. Discuss any acid-suppressive medication, dose change, or planned discontinuation with a qualified physician. Long-term acid suppression is not benign — review the need at least annually with your prescriber.

Aiheeseen liittyvät vaihtoehdot

Muut tuotteet Yleinen terveys joita asiakkaat myös katsovat:

More options in Acid Reflux Treatment

Luokiteltu MedsBase-tilausmäärän mukaan — mitä muut asiakkaat tässä kategoriassa valitsevat.

Vahvuus

40 mg

Määrä

1 Vial/s, 2 Vial/s, 3 Vial/s, 6 Vial/s

Arvostelut

Ei vielä arvosteluja

Lisää arvostelu
Pantocid Injection Pantocid Injection
Arvosana*
0/5
* Arvosana vaaditaan
* Vastaus vaaditaan
Arvostelusi
* Arvostelu vaaditaan
Nimi
* Nimi on pakollinen
Lisää kuvia tai video arvosteluusi

Kysymykset ja vastaukset

Esitä kysymys
Pantocid Injection Pantocid Injection
Kysymyksesi
* Kysymys on pakollinen
Nimi
* Nimi on pakollinen
Ei vielä kysymyksiä